The impact of short-term administration of dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes and renal insufficiency undergoing percutaneous coronary intervention
Short-term (<2 weeks) dapagliflozin administration may increase the risk of CIAKI in T2DM patients with renal insufficiency undergoing PCI. It is recommended to avoid initiating dapagliflozin in high-risk CIAKI patients prior to PCI.
Authors
- Manxi Liu
- Naikuan Fu (ORCID: https://orcid.org/0000-0001-8985-6486)
- Shicheng Yang (ORCID: https://orcid.org/0000-0002-9083-5575)
- Shuang Zhu (ORCID: https://orcid.org/0000-0002-1885-6881)
- Xiangwei Zhai (ORCID: https://orcid.org/0000-0003-2967-5573)
- Peng Zhang (ORCID: https://orcid.org/0009-0005-2930-6956)
Institutions
- Tianjin University (CN)
- Tianjin Chest Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-12-15
- DOI
- https://doi.org/10.3389/fmed.2025.1744473
- Citations
- 2
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Tianjin Municipal Health Commission